Exenatide vs Rituximab

Exenatide vs Rituximab: Overview

This comparison examines the pharmacological differences between Exenatide and Rituximab.

Mechanism of Action

Exenatide: Synthetic exendin-4 GLP-1 receptor agonist enhancing glucose-dependent insulin secretion.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Exenatide — 2.4 hours; Rituximab — 22 days.

Chemical Properties

Type: Exenatide — Protein; Rituximab — Antibody.